Get access

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the safety and efficacy of PDE4 inhibitors in the management of stable chronic obstructive pulmonary disease (COPD). Outcomes to be assessed will include lung function, quality of life, clinical outcomes, symptoms, functional exercise capacity, and adverse effects.